Willow Biosciences Inc. (TSX:WLLW)
Canada flag Canada · Delayed Price · Currency is CAD
0.0350
-0.0050 (-12.50%)
May 22, 2025, 2:26 PM EDT
-58.82%
Market Cap 5.07M
Revenue (ttm) 6.37M
Net Income (ttm) -4.15M
Shares Out 144.85M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,093,358
Average Volume 1,216,655
Open 0.0400
Previous Close 0.0400
Day's Range 0.0300 - 0.0400
52-Week Range 0.0050 - 0.1450
Beta 1.40
RSI 62.72
Earnings Date May 9, 2025

About Willow Biosciences

Willow Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical products in the United States. The company has licensing and development partnership with Laurus Labs to develop and commercialize active pharmaceutical ingredients and other ingredients. Willow Biosciences Inc. was founded in 2019 and is headquartered in Calgary, Canada. [Read more]

Sector Healthcare
Founded 2019
Employees 19
Stock Exchange Toronto Stock Exchange
Ticker Symbol WLLW
Full Company Profile

Financial Performance

In 2024, Willow Biosciences's revenue was 4.66 million, an increase of 297.78% compared to the previous year's 1.17 million. Losses were -6.19 million, -52.50% less than in 2023.

Financial Statements

News

There is no news available yet.